the new vector will ultimately be for hep b.

First 23 Last

Share
Profile

Follow
inapinchpenny

335 Posts.

23/06/15

12:54

Post #: 15514146
Share

Originally posted by Hoyland ↑

Has anyone else noticed that the Tribetarna trial has been relegated to the second division? Funds from this IPO will be used to fund trials for HCV, HBV and AMD but not for Tribetarna - this program will only be funded to IND. Frankly, this is joke! This was a program that was to go to trial in 2012. Only a year ago PF was telling the world that the trial will start in 2015. Now, an extra $60M will not get it into the clinic. What happened to the advance payment of $3M that was paid to the CRO? How can anyone believe any of the statements made by the company when they never seem to achieve what they say they will do?

At least the IPO is underwritten and so most of the capital is assured but I don't get the feeling that the increased capital will be used in a way that will stimulate real interest. It is a harsh call but I suspect that the underwriter may be left with egg on their face. I said in a previous post that management needed an ace up its sleeve if existing investors were to get something out of the IPO, so far, I cannot see it.

Did anyone notice that our existing capital plus the new capital is only predicted to last 24 months? In other words, more capital raising in two years.

The statement that one possible development for TT-034 could be the application of a new vector for a second generation product does not inspire me.

All in all, this seems to be the same old, same old that I have read before every other capital raising.

Expand

the new vector will ultimately be for hep b.

BLT Price at posting: 78.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

ASX hits all time high out the gate on Friday trades following bullish US inflation data

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Bitcoin investors need to know the risks

There are more pages in this discussion • 31 more messages in this thread...

First 23 Last

Add BLT (ASX) to my watchlist

the new vector will ultimately be for hep b.

Top Stories

Nimy to raise $1.21M to explore 'newsy' WA targets

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Immutep reports strong response rate from immunotherapies treating carcinomas

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Bitcoin investors need to know the risks

Featured News